Skip to: Main Content Search Main Navigation Audience Navigation

A Diabetes-Free Society

Clinical Trials

Our clinical trials allow for researchers to make medical advances in Diabetes.  The studies cover prevention, diagnosis and treatment of the disease.  Our aim is to improve the quality of life for all of those living with diabetes.

The Clinical Research Unit at the Heritage College of Osteopathic Medicine is staffed by members of the Diabetes Institute.  The unit handles phases II, III, and IV of corporate-sponsored trials and investigator trials.  If you are interested in participating in a Clinical Trial call Cammie Starner at 740-566-4873.

 STARNER       Shubrook       Petrik
      Cammie Starner                      Jay Shubrook                        Lynn Petrik
       Research Nurse                          Director                          Research Nurse
   starnerc@ohio.edu              shubrook@ohio.edu              petrikl@ohio.edu

Current Corporate-Sponsored Studies:

Project Title:    Natural History Study of the Development of Type 1 Diabetes
Primary Investigator:  Schwartz
Investigators:  Shubrook
Sponsor:  FSU

Project Title:    CV181-058 A -multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of Saxagliptin (BMS-477118) as monotherapy in pediatric patients with Type 2 diabetes
Primary Investigator: Shubrook
Investigator:   Guo
Sponsor:  BMS

Project Title:    CV181-147 A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of Saxagliptin (BMS-477118) as in addition to Metformin in pediatric patients with Type 2 diabetes
Primary Investigator:  Shubrook
Investigator:   Guo
Sponsor:  BMS

Project Title:    SYR-322_402 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome
Primary Investigator:  Shubrook
Investigators:  Koshal
Sponsor:  Takeda

Project Title:    INSPIRE Intensive Insulin Regimen as a Primary Treatment of New Onset of Type 2 DM ATHENS SITE
Primary Investigator:  Shubrook
Investigators:  Schwartz
Sponsor:  Ohio University

Project Title:    INSPIRE Intensive Insulin Regimen as a Primary Treatment of New Onset of Type 2 DM WESTERN UNIVERSITY SITE
Primary Investigator:  Metha
Investigators:  Sathananthan
Sponsor:  Ohio University

Project Title:    ASPIRE CEP237/Z25/D (Automation to Simulate Pancreatic Insulin Response): Pivotal In Home study to determine safety and efficacy of the LGS feature in sensor-augmented pumps
Primary Investigator:  Schwartz
Investigators:  Shubrook
Sponsor:  Medtronic

 

Investigator Studies:

Project Title:    Program Active II: An Interdisciplinary Approach to Depression Treatment in T2DM in Rural Communities
Primary Investigator:  Pillay
Investigators:  Shubrook, Schwartz
Sponsor:  NIH

Project Title:    Help Your Patients Know Their Numbers:  The Critical Role of Diabetes Numeracy in Adherence to Diabetes Treatment
Primary Investigator:  Zaugg
Investigators:  Dogbey, Shubrook
Sponsor:  Ohio University PACE

Project Title:    Using Continuous Glucose Monitoring for Hypoglycemia Occurence in Type 2 DM Patients on Different Treatment Modalities in an Outpatient Clinic Setting, iPro Sensor
Primary Investigator:  Gehlaut
Investigators:  Shubrook, Schwartz, Dogbey
Sponsor:  Heritage Foundation

Project Title:    A Comparison of Two Diagnostic Criteria for Gestational Diabetes
Primary Investigator:  Gerome
Investigators:  Bucher
Sponsor:  Ohio University

Project Title:    Progesterone Metabolism in Women with Polycystic Ovarian Syndrome
Primary Investigator:  Healy
Investigators:  Gerome, Schwartz
Sponsor:  Ohio University

03/13/13